BACTAVIVA AB
1Patents
1Active
1Granted
38Portfolio score
Filing activity: Jan 19, 2018 → Jan 19, 2018
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11045501B2 | Autologous fecal sample for use in the treatment of microbial dysbiosis | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.